Ara h 1 Peptide Immunotherapy Ameliorates Peanut-Induced Anaphylaxis

Conclusions The ability of peptide immunotherapy to ameliorate signs and symptoms of anaphylaxis in an experimental, murine model supports the further evaluation of this form of therapy in clinical peanut allergy.

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 135; no. 2; p. AB158
Main Authors Simms, Elizabeth, MSc, Rudulier, Christopher, Wattie, Jennifer, Kwok, William W., PhD, James, Eddie A., PhD, Moldaver, Daniel M, Jordana, Manel, MD, PhD, Larché, Mark, PhD
Format Journal Article
LanguageEnglish
Published St. Louis Elsevier Limited 01.02.2015
Subjects
Allergies
Allergy and Immunology
Food allergies
Immunotherapy
Peptides
Rodents
Online AccessGet full text

Cover

More Information
Summary:Conclusions The ability of peptide immunotherapy to ameliorate signs and symptoms of anaphylaxis in an experimental, murine model supports the further evaluation of this form of therapy in clinical peanut allergy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.12.1456